Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
about
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesIn vitro and in vivo activities of sitafloxacin against Chlamydia sppFastidious intracellular bacteria as causal agents of community-acquired pneumonia.Treatment of Chlamydial infections: 2014 update.Treatment of chlamydial infections.In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.
P2860
Q33905858-DEBD8E62-C293-409E-A0AB-B5CBFB289F1AQ33983469-0D35B861-73EC-472B-ACFA-CD099733A381Q37768416-88A56708-EFA5-45B9-AEFE-FCC79DD900A9Q37842306-5413A074-ED86-4B29-8609-7D8F9FD59BDCQ37849351-959D3991-D060-4900-BFF5-3D08A83D520EQ37872796-F1FD3E2B-4BFC-4367-AFF9-289F36CD6439Q37872800-D75F8EC7-C618-4E31-93AF-2F965868DC56
P2860
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@en
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@nl
type
label
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@en
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@nl
prefLabel
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@en
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@nl
P2860
P1476
Microbiological efficacy of le ...... a due to Chlamydia pneumoniae.
@en
P2093
Hammerschlag MR
P2860
P356
10.1128/AAC.44.5.1409-1409.2000
P407
P577
2000-05-01T00:00:00Z